(1950–1979) RA – Diagnosis, Manifestations, and Outcomes Poster IV

Monday, November 14, 2022

1:00 PM – 3:00 PM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

1:00 PM – 3:00 PM Eastern Time

Morbidities Associated with Serious Infections in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Bradly Kimbrough, MD – Mayo Clinic Rochester
1:00 PM – 3:00 PM Eastern Time

Interleukin 1 Receptor Antagonist Relation to Cardiovascular Disease in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Claudia De Luis Zarate, Sr., MD – Hospital Universitario de Canarias
1:00 PM – 3:00 PM Eastern Time

Burden of Disease in Refractory Rheumatoid Arthritis
Abstract Poster Presenter: Kristin Wipfler, PhD – FORWARD, The National Databank for Rheumatic Diseases
1:00 PM – 3:00 PM Eastern Time

Mortality in Rheumatoid Arthritis: Changing Causes and Predictive Factors. Study of a Cohort Followed Prospectively
Abstract Poster Presenter: Cristina Corrales, MD – HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
1:00 PM – 3:00 PM Eastern Time

Development of the Patient-Important Outcomes Data Repository (PIONEER) for Rheumatic Diseases; An Enhanced Database Combining Electronic Medical Data with Insight from Chart Reviews
Abstract Poster Presenter: Simon Helfgott, MD – BWH- HMS
1:00 PM – 3:00 PM Eastern Time

Predictive Factor of Spontaneous Regression in Methotorexate-associated Lymphoproliferative Disorders with RA Patients
Abstract Poster Presenter: Tomohiro Kameda, MD – Kagawa University
1:00 PM – 3:00 PM Eastern Time

Functional Disabilities in Hands Precede Those in Feet in Patients Progressing from Clinically Suspect Arthralgia to Rheumatoid Arthritis; A Longitudinal Observational Study
Abstract Poster Presenter: Sarah Khidir, MD, MA – Leiden University Medical Center
1:00 PM – 3:00 PM Eastern Time

Detangling Heterogeneity in Contemporary Undifferentiated Arthritis – a Large Cohort Study Using Latent Class Analysis
Abstract Poster Presenter: Nikolet den Hollander, MD – Leids Universitair Medisch Centrum
1:00 PM – 3:00 PM Eastern Time

The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry
Abstract Poster Presenter: Sabine Dieperink, MD – Copenhagen University Hospital - Rigshospitalet
1:00 PM – 3:00 PM Eastern Time

Increased Mortality in Patients with RA-Associated Interstitial Lung Disease: Data from a French Administrative Healthcare Database
Abstract Poster Presenter: Pierre-Antoine Juge, MD, PhD – Rheumatology department, Bichat Hospital
1:00 PM – 3:00 PM Eastern Time

Impact of Delaying Initiation of Methotrexate by One Month on the Outcome of RA at One Year
Abstract Poster Presenter: Jacques Morel, MD, PhD – Protocole thérapeutique immuno-rhumatologie
1:00 PM – 3:00 PM Eastern Time

COVID-19 mRNA Vaccine Induced Antibody Titers and IFN-g Responses Are Decreased in Persons with Rheumatoid Arthritis and Older Age
Abstract Poster Presenter: Holly Dudley, BS – Case Western Reserve University
1:00 PM – 3:00 PM Eastern Time

Idiopathic Pulmonary Fibrosis Molecular Profile Correlates with Stage of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Poster Presenter: Dana Ascherman, MD – University of Pittsburgh
1:00 PM – 3:00 PM Eastern Time

Lipid Screening and Statin Use in Rheumatoid Arthritis Patients in an Underserved Population
Abstract Poster Presenter: Colleen O'Neill, MD – Dell Seton Ascension
1:00 PM – 3:00 PM Eastern Time

Systematic Screening of Multimorbidities Results in an Increased Intake of Comorbidity Preventive Medications and a Decreased Hospitalization Rate
Abstract Poster Presenter: Claire Daien, MD, PhD – University hospital
1:00 PM – 3:00 PM Eastern Time

Autoantibodies Against a Specific 25-mer Peptide from P. Gingivalis Are Present in Sera of Patients with Rheumatoid Arthritis and Early Arthritis
Abstract Poster Presenter: Gregory Tsay, MD – China Medical University Hospital
1:00 PM – 3:00 PM Eastern Time

Favorable Effects of TNF Inhibitors on Intima Media Thickness and Arterial Stiffness in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Abstract Poster Presenter: Eva van Geel, MD, MSc – Amsterdam Rheumatology and immunology Center
1:00 PM – 3:00 PM Eastern Time

Sex Differences in Employment Outcomes in Patients with Recent Onset Rheumatoid Arthritis
Abstract Poster Presenter: Carol Hitchon, MD, MSc – University of Manitoba
1:00 PM – 3:00 PM Eastern Time

Dysregulation of γδ-T Cells in Individuals at Risk of Developing Rheumatoid Arthritis
Abstract Poster Presenter: Klara Prajzlerova, PhD – Institute of Rheumatology
1:00 PM – 3:00 PM Eastern Time

The Potential Diagnostic Value of C-X-C Motif Chemokine 13 (CXCL13) in Seronegative Arthritis
Abstract Poster Presenter: Silvia Piantoni, MD, PhD – ASST Spedali Civili and University of Brescia
1:00 PM – 3:00 PM Eastern Time

Detecting Inflammatory Changes in Seronegative Inflammatory Arthritis with Use of Musculoskeletal Ultrasound Studies
Abstract Poster Presenter: Clarice Lin, MD – University at Buffalo
1:00 PM – 3:00 PM Eastern Time

Cumulative Joint Inflammation Is Associated with Local Joint Damage Progression in Rheumatoid Arthritis Despite Long-Term Targeted Treatment
Abstract Poster Presenter: Sascha Heckert, MD – Leiden University Medical Centre
1:00 PM – 3:00 PM Eastern Time

Comprehensive Investigation of Pain and Inflammation in Rheumatoid Arthritis from a Multidisciplinary Approach
Abstract Poster Presenter: Lilla Gunkl-Tóth, MD, PhD – University of Pécs; Semmelweis University
1:00 PM – 3:00 PM Eastern Time

Association Between Activity Limitations, Sleep Disturbance, Pain Sensitivity, Pain Intensity, and Widespread Pain in Adults with Rheumatoid Arthritis
Abstract Poster Presenter: Burcu Aydemir, PhD – Northwestern University
1:00 PM – 3:00 PM Eastern Time

Which ACR Response Definition Should Be Used for Disease Activity Claims in Approval Studies of Rheumatoid Arthritis? A Systematic Evaluation
Abstract Poster Presenter: Andreas Kerschbaumer, MD – Medical University of Vienna
1:00 PM – 3:00 PM Eastern Time

Identifying MicroRNAs Associated with Neuropathic Pain in Patients with Rheumatoid Arthritis (RA)
Abstract Poster Presenter: Veronika Zenkeviciute, BSc – John Jay College of Criminal Justice, CUNY
1:00 PM – 3:00 PM Eastern Time

Outcomes of the First Episode of STEMI in Rheumatoid Arthritis from the National Inpatient Sample Database 2016-2019
Abstract Poster Presenter: Amar Suwal, MD – Reading hospital- Towerhealth
1:00 PM – 3:00 PM Eastern Time

Tc99m Tilmanocept Imaging Predicts Clinical Response in Rheumatoid Arthritis Patients Beginning New Anti-TNFα Therapy
Abstract Poster Presenter: Jonathan Graf, MD – Ucsf
1:00 PM – 3:00 PM Eastern Time

Using Administrative Health Data to Construct a Frailty Index as a Measure of Susceptibility to Adverse Health Outcomes Among Individuals with Rheumatoid Arthritis
Abstract Poster Presenter: Alexandra Legge, MD, FRCPC, MSc – Dalhousie University
1:00 PM – 3:00 PM Eastern Time

Tc99m Tilmanocept Imaging Can Differentiate the Fibroid Pathotype of Rheumatoid Arthritis from Non-Fibroid Pathotypes in Patients
Abstract Poster Presenter: Costantino Pitzalis, MD, PhD, FRCP – QMUL